Navigation Links
Major Milestone Reached in Global Maternal Health
Date:3/26/2009

10,000 Women with Fistula Receive Life-Changing Surgery

WASHINGTON, March 26 /PRNewswire-USNewswire/ -- The U.S. Agency for International Development (USAID) and EngenderHealth announced today that 10,000 women have received surgery for fistula with U.S. support since 2005. Fistula, a devastating vaginal injury affecting millions of women in developing countries, can be surgically repaired, but most of those with the condition lack access to a skilled surgeon or health center, making treatment out of reach.

"Today, the United States has achieved a major milestone in improving global maternal health -- giving 10,000 women hope for a better life. None of this would have been possible without the dedication of the local medical teams, government officials, international partners, and the support of the American people," said Gloria Steele, acting assistant administrator in USAID's Bureau for Global Health. "But our work is just beginning."

Four years ago, USAID launched a global effort to both treat and prevent fistula. To date, through initiatives such as the Fistula Care project, and in collaboration with local governments, regional healthcare organizations and faith based organizations, medical teams in 12 countries and 25 health facilities across Africa and Asia have been trained to provide surgery for fistula -- which can be repaired in up to 90 percent of cases.

Fistula is an injury caused by prolonged, obstructed labor that can occur when the head of the baby cannot pass safely through the mother's birth canal. The baby often dies and the mother is left with an abnormal opening in the birth canal and chronic incontinence. If left untreated, fistula can lead to skin ulcerations and infections, kidney disease, social isolation, and even death.

Fistula is almost entirely preventable. Making voluntary family planning available to all could reduce maternal disability and death by at least 20 percent. Complementing that with skilled attendance at all births and improving access to emergency obstetric care and caesarian section could make fistula as rare as it is in the industrialized world. USAID and its partners include strong prevention efforts in their programs, engaging all levels of society -- raising awareness of fistula and its underlying causes that include early pregnancy, poverty, and a lack of girls' education and women's empowerment.

USAID's Fistula care project is managed by EngenderHealth and its partners IntraHealth, CARE, Meridian Group International, Adventist Development and Relief Agency (ADRA) and Society for Women and AIDS in Africa (SWAA). In addition to increasing the number of trained surgeons and leading prevention efforts, Fistula Care project sites offer counseling and support to help women reintegrate into communities that may have shunned them.

Visit www.fistulacare.org for more information or contact fistulacare@engenderhealth.org

For more information about USAID and its programs, please visit: www.usaid.gov.

The American people, through the U.S. Agency for International Development, have provided economic and humanitarian assistance worldwide for nearly 50 years.

Public Information: 202-712-4810


'/>"/>
SOURCE U.S. Agency for International Development
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents
2. SEIU, CNA/NNOC Announce Major Accord
3. Major Asthma Research Discovery Could Lead to New Drugs
4. Health Insurers to Make Major Investment in Primary Care, Patients and Physicians to Benefit
5. Non-Profit Seeks Partners for Major Cover-Up
6. Work Atmosphere Is Worried, Panicky, Say Majority of U.S. Employees
7. Injected Medication Errors a Major Problem
8. Consumers Win Major Victory Over Seafood Scaremongers
9. Leading German Healthcare Group Selects Equipment and Software from Varian Medical Systems for Major Replacement Project
10. New Data Reveals That Gaps in Coverage for Those With Private Insurance Are Major Barriers to Colorectal Cancer Screening
11. Innovative Plans by Major Arizona-Based Developer Sparks Landmark Energy Conservation Legislation in Multiple States to Urge Federal Action at Wall Street Journal Conference This Week with Gore, Google CEO & T. Boone Pickens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , ... April 24, 2017 , ... ... they are seeking public support to bring their novel lifesaving device for the ... device packed with medical-grade sensors, specially designed to read a child’s vital signs, ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... expected to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As ... use of this type of healthcare model in the diagnosis and treatment of ...
(Date:4/24/2017)... Montclair, NJ (PRWEB) , ... April 24, 2017 , ... ... International Plaza Hotel, 4200 Jim Walter Blvd, for an educational and exciting 2-day program. ... all of our staff hearing this before they approach patients” about the course entitled ...
(Date:4/24/2017)... ... ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: a guide to ... Navigate Life Issues” is the creation of published author, Rachel Jamerson, writer of 25 ... CONTACT USA, and former member of the American Association of Christian Counselors. Rachel ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, a pre-clinical ... for the treatment of Acute Ischemic Stroke (AIS), today announced it has appointed ... product advances towards regulatory and clinical phases. , "This is another important step ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
Breaking Medicine Technology: